Markus A - Search Results

1

Bacteremia due to fluoroquinolone-resistant Escherichia coli in two immunocompromised patients.

Kern WV, Markus A, Andriof E. Kern WV, et al. Among authors: markus a. Eur J Clin Microbiol Infect Dis. 1994 Feb;13(2):161-5. doi: 10.1007/BF01982191. Eur J Clin Microbiol Infect Dis. 1994. PMID: 8013490

2

Lues maligna, or ulceronodular syphilis, in a man infected with human immunodeficiency virus: case report and review.

Sands M, Markus A. Sands M, et al. Among authors: markus a. Clin Infect Dis. 1995 Feb;20(2):387-90. doi: 10.1093/clinids/20.2.387. Clin Infect Dis. 1995. PMID: 7742445 Review.

3

Activity of levofloxacin, ofloxacin, D-ofloxacin and ciprofloxacin against systemic and respiratory tract infections in laboratory animals.

Klesel N, Geweniger KH, Koletzki P, Isert D, Limbert M, Markus A, Riess G, Schramm H, Seibert G, Iyer P, et al. Klesel N, et al. Among authors: markus a. Drugs. 1995;49 Suppl 2:211-4. doi: 10.2165/00003495-199500492-00045. Drugs. 1995. PMID: 8549307 No abstract available.

4

Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals.

Klesel N, Geweniger KH, Koletzki P, Isert D, Limbert M, Markus A, Riess G, Schramm H, Iyer P. Klesel N, et al. Among authors: markus a. J Antimicrob Chemother. 1995 Jun;35(6):805-19. doi: 10.1093/jac/35.6.805. J Antimicrob Chemother. 1995. PMID: 7559192

5

Antibacterial activity in vitro of cefpirome against clinical isolates causing sexually transmitted diseases.

Limbert M, Seibert G, Winkler I, Isert D, Klesel N, Markus A, Schrinner E. Limbert M, et al. Among authors: markus a. J Antimicrob Chemother. 1992 Apr;29 Suppl A:13-7. doi: 10.1093/jac/29.suppl_a.13. J Antimicrob Chemother. 1992. PMID: 1318294

6

RU 29 246, the active compound of the cephalosporin prodrug-ester HR 916. III. Pharmacokinetic properties and antibacterial activity in vivo.

Klesel N, Adam F, Isert D, Limbert M, Markus A, Schrinner E, Seibert G. Klesel N, et al. Among authors: markus a. J Antibiot (Tokyo). 1992 Jun;45(6):922-31. doi: 10.7164/antibiotics.45.922. J Antibiot (Tokyo). 1992. PMID: 1500360 Free article.

7

The in-vitro antibacterial activity of a combination of cefpirome or cefoperazone with vancomycin against enterococci and Staphylococcus aureus.

Seibert G, Isert D, Klesel N, Limbert M, Markus A, Schrinner E. Seibert G, et al. Among authors: markus a. J Antimicrob Chemother. 1992 Apr;29 Suppl A:25-30. doi: 10.1093/jac/29.suppl_a.25. J Antimicrob Chemother. 1992. PMID: 1601753

8

Pharmacokinetics of cefpirome administered intravenously or intramuscularly to rats and dogs.

Isert D, Klesel N, Limbert M, Markus A, Seibert G, Schrinner E. Isert D, et al. Among authors: markus a. J Antimicrob Chemother. 1992 Apr;29 Suppl A:31-7. doi: 10.1093/jac/29.suppl_a.31. J Antimicrob Chemother. 1992. PMID: 1601754

9

Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin.

Limbert M, Isert D, Klesel N, Markus A, Seeger K, Seibert G, Schrinner E. Limbert M, et al. Among authors: markus a. Antimicrob Agents Chemother. 1991 Jan;35(1):14-9. doi: 10.1128/AAC.35.1.14. Antimicrob Agents Chemother. 1991. PMID: 2014969 Free PMC article.

10

Comparative chemotherapeutic activity of cefpirome and imipenem in experimental infections.

Klesel N, Isert D, Limbert M, Markus A, Seibert G, Schrinner E. Klesel N, et al. Among authors: markus a. J Antibiot (Tokyo). 1990 Jan;43(1):100-6. doi: 10.7164/antibiotics.43.100. J Antibiot (Tokyo). 1990. PMID: 2407707 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters